INDEPENDENTLY TESTED • VERIFIED QUALITY ✓ Purity — HPLC analysis ✓ Identity — Mass spectrometry ✓ Net content — Verified on the 5 mg vial SEMA 5 mg and 10 mg share the same peptide batch. The tested sample was a 5 mg vial. VERIFY COA AT FREEDOM DIAGNOSTICS → Enter search code: Suaw2605040573SEMA is a synthetic metabolic research peptide belonging to a class of regulatory compounds associated with incretin-related signaling pathways. It is widely studied for its interaction with receptor-mediated mechanisms involved in glucose handling, energy balance, and systemic metabolic regulation. Research interest also extends to its role in broader signaling networks, including those associated with cardiovascular function and neuroendocrine communication, making it a key compound in modern metabolic research models.

Sermorelin is a synthetic peptide derived from Growth Hormone-Releasing Hormone (GHRH) that stimulates the pituitary gland to increase endogenous growth hormone secretion. By activating GHRH receptors, Sermorelin promotes physiological GH release and enhances downstream IGF-1 production, supporting anabolic and regenerative signaling. Research suggests it may be relevant in studies involving body composition improvement, bone density support, metabolic regulation, and tissue repair. Additional research interest includes potential cardiovascular recovery effects through reduced scar remodeling, neuroprotective support via IGF-1-mediated neuronal resilience, and systemic benefits in chronic inflammation-related conditions. Due to its feedback-regulated mechanism and sustained receptor responsiveness, Sermorelin remains an important peptide in research related to endocrine aging, regeneration, and long-term metabolic health.

Setmelanotide is a synthetic peptide and potent melanocortin 4 receptor (MC4R) agonist studied for its ability to restore satiety signaling in rare genetic disorders such as POMC deficiency, PCSK1 deficiency, and leptin-related pathway dysfunction. It works by directly activating MC4R, bypassing upstream genetic defects that impair production of α-MSH and other satiety mediators. Research suggests that setmelanotide has significantly higher potency than endogenous α-MSH and may reduce hyperphagia and support weight loss in genetically defined obesity conditions. Its activity may be influenced by its atypical bitopic binding behavior, interacting with both orthosteric and putative allosteric receptor sites, potentially contributing to improved receptor specificity and a distinct signaling profile compared to earlier MC4R agonists.

Taltirelin is a synthetic TRH analogue studied primarily for its effects in spinocerebellar degeneration and related motor coordination disorders. Acting as a biased superagonist at TRH-R1, it influences central neurotransmission and has been investigated for neuroprotective, anti-ataxic, and pro-cognitive effects. Research suggests taltirelin may modulate multiple neurotransmitter systems, including acetylcholine, dopamine, serotonin, and noradrenaline, contributing to interest in its potential relevance for memory impairment, depressive-like conditions, arousal regulation, and fatigue-related disorders. Additional studies have explored its antinociceptive properties and possible effects on neurite outgrowth and spinal cord-related neural recovery, making it a notable peptide in experimental research involving neurodegeneration, cognition, and neurological resilience.

Tesamorelin is a synthetic Growth Hormone-Releasing Hormone (GHRH) analogue designed for improved stability and extended activity in human plasma. By activating pituitary GHRH receptors, it stimulates endogenous growth hormone release while maintaining physiological pulsatile secretion patterns. This leads to increased downstream IGF-1 production, supporting anabolic and metabolic regulation. Research suggests tesamorelin may reduce visceral adipose tissue, support lean muscle maintenance, and influence metabolic health. It has been extensively studied in HIV-associated lipodystrophy, where reductions in abdominal fat have been associated with improved body composition markers and potential improvements in lipid-related cardiovascular risk factors. Emerging research also suggests possible relevance in cognitive aging and neuroendocrine function, as GH and IGF-1 pathways contribute to synaptic plasticity and brain metabolism.

Testagen is a bioregulatory peptide studied for its potential influence on endocrine balance, particularly in relation to thyroid hormone regulation and testosterone-related signaling. It has been described as a peptide capable of penetrating cellular structures and potentially influencing gene regulatory pathways. Research discussions suggest Testagen may support pituitary activity, increasing thyroid-stimulating hormone (TSH) output and indirectly supporting thyroid hormones T3 and T4, contributing to improved metabolism and energy regulation. It has also been explored for potential relevance in testosterone decline research, age-related vitality reduction, and hormonal imbalance-related conditions. Additional research interest includes its possible influence on hemostasis through thyroid-driven pathways and its potential immune-support relevance by modulating cellular differentiation and immune aging mechanisms.

Thyroidget (Asp–Trp) is a short bioregulatory peptide studied for its potential antioxidant and anti-inflammatory properties. Research suggests it may support cellular protection against oxidative stress and modulate inflammatory signaling pathways, making it relevant in studies involving chronic inflammatory disorders, cardiovascular risk models, and systemic aging processes. Due to the thyroid gland’s high metabolic activity and vulnerability to oxidative injury, Thyroidget has attracted interest as a peptide potentially supporting thyroid homeostasis and endocrine resilience, including research contexts related to autoimmune thyroid conditions. Emerging investigations also suggest possible neuroprotective relevance in models of neurodegenerative disease. Thyroidget is considered moderately water-soluble, with solubility influenced by pH, concentration, and ionic conditions.

INDEPENDENTLY TESTED • VERIFIED QUALITY ✓ Purity — HPLC analysis ✓ Identity — Mass spectrometry ✓ Net content  VERIFY COA AT FREEDOM DIAGNOSTICS → Enter search code: Suaw2605040575Tirz is a synthetic dual-receptor metabolic research peptide designed to interact with GIP-associated and GLP-related signaling pathways. By targeting multiple incretin-associated receptor systems simultaneously, it has become a key subject of investigation in studies focused on metabolic regulation, energy balance, and coordinated signaling networks. Its multi-pathway activity supports research into integrative metabolic processes, cellular signaling dynamics, and system-wide regulatory mechanisms involved in nutrient-response and energy homeostasis.

Thyrotropin-Releasing Hormone (TRH) is a naturally occurring tripeptide neurohormone best known for stimulating pituitary release of TSH and regulating thyroid hormone production. Beyond its classical endocrine role, TRH is widely distributed throughout the CNS and peripheral tissues, suggesting broader biological functions. Research indicates that TRH may influence immune development and immune homeostasis through interactions with cytokine signaling pathways, supporting its relevance in inflammatory disorders and cytokine-induced sickness behavior models. Animal studies have suggested that TRH may improve aging-related metabolic and hormonal parameters, including support for reproductive function, reduction of age-associated kidney degeneration, and modulation of fat metabolism. Additional investigations have explored TRH’s potential role in thymus-related immune resilience and pancreatic metabolic regulation.

α-Klotho is a transmembrane and soluble endocrine protein first identified in 1997 and now widely recognized as a key candidate in aging biology. It is expressed predominantly in the kidney and choroid plexus of the brain, and its soluble form circulates in blood, urine, and cerebrospinal fluid. Membrane α-Klotho functions as an essential co-receptor for FGF23, regulating phosphate and vitamin D metabolism. Soluble α-Klotho is studied for its broader endocrine-like effects, including modulation of oxidative stress responses, inflammatory signaling, IGF-1 and mTOR pathways, and Wnt-associated tissue remodeling. Experimental models show that Klotho deficiency is linked to accelerated aging-like phenotypes such as vascular dysfunction, sarcopenia, cognitive decline, cardiac fibrosis, and osteopenia, while elevated Klotho expression is associated with improved cognition, delayed vascular aging, enhanced muscle regeneration, and increased lifespan. Due to its connection with senescence biology, SASP-driven inflammation, kidney decline, and neurodegenerative processes, α-Klotho remains a central molecule in research focused on longevity, metabolic regulation, and systemic resilience.